We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Glaucoma in the Israeli Arab Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01546740
Recruitment Status : Unknown
Verified March 2012 by Ziv Hospital.
Recruitment status was:  Recruiting
First Posted : March 7, 2012
Last Update Posted : March 7, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
there is a variety of glaucoma prevalence within different populations. this study examine the prevalence of glaucoma in the Arab population in Israel' as well as the demographic variables and the compliance to treatment in the population.

Condition or disease
Glaucoma

Detailed Description:
from Medical records of primary care clinic in the city of Tira. the patients are recruited, all glaucoma patients are above age of 20 years. they must suffer from CDR >= 0.5 with/without asymmetry with the other eye. or they suffer from glaucomatous damage to the visual fields.

Study Design

Study Type : Observational
Estimated Enrollment : 15000 participants
Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Glaucoma Prevalence in the Israeli Arab Population
Study Start Date : January 2012
Estimated Primary Completion Date : April 2012
Estimated Study Completion Date : May 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Glaucoma patients
all the ,medical records of patients who were diagnosed with primary open angle glaucoma, closed angle , pseudoexfoliative and neovascular glaucoma.


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinics from 1 Arab city in the center of Israel
Criteria

Inclusion Criteria:

  • Cup-to-disk ratio (CDR) > 0.5 with asymmetry between the eyes
  • Intraocular pressure (IOP) > 23 mm Hg
  • Damage to the field of vision
  • Age- above 20 Yrs. old

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01546740


Contacts
Contact: Joseph Pikkel, M.D +972508434206 pikel.y@ziv.health.gov.il
Contact: Otzem Chassid, M.D +972506266059 otzem.c@ziv.health.gov.il

Locations
Israel
Ziv Medical Center Recruiting
Safed, Israel, 13120
Contact: Joseph Pikkel, M.D    +972508434206    pikel.y@ziv.health.gov.il   
Contact: Otzem Chassid, M.D    +972506266059    otzem.c@ziv.health.gov.il   
Sponsors and Collaborators
Ziv Hospital
Investigators
Principal Investigator: Joseph Pikkel, M.D Ziv Medical Center
More Information

Responsible Party: Ziv Hospital
ClinicalTrials.gov Identifier: NCT01546740     History of Changes
Other Study ID Numbers: ZIV-0060-11
First Posted: March 7, 2012    Key Record Dates
Last Update Posted: March 7, 2012
Last Verified: March 2012

Keywords provided by Ziv Hospital:
Glaucoma, Compliance, Prevalence

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases